INTECH Investment Management’s Xenon Pharmaceuticals XENE Stock Holding History

INTECH Investment Management’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.31M	Buy	21,758 +2,696	+14%	+$150K	0.01%	899
2026 Q1	$1.11M	Sell	19,062 -6,778	-26%	-$312K	0.01%	972
2025 Q4	$1.16M	Buy	25,840 +2,754	+12%	+$116K	0.01%	1054
2025 Q3	$927K	Sell	23,086 -11,226	-33%	-$395K	0.01%	1210
2025 Q2	$1.07M	Buy	+34,312	New	+$1.12M	0.01%	1148

Other funds holding XENE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

INTECH Investment Management's XENE Position: Q2 2026 in Review

INTECH Investment Management increased its Xenon Pharmaceuticals (XENE) stake by 14% in Q2 2026, buying an estimated $150K and bringing the position to 21,758 shares worth $1.31M. The position accounts for 0.01% of the portfolio, ranked #899.

INTECH Investment Management first reported a position in XENE in Q2 2025 and has held it in 5 quarters since. 315 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

INTECH Investment Management held 21,758 shares of Xenon Pharmaceuticals worth $1.31M as of Q2 2026.
INTECH Investment Management bought 2,696 Xenon Pharmaceuticals shares in Q2 2026, an estimated $150K.
Xenon Pharmaceuticals made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #899 holding.
INTECH Investment Management first reported a position in Xenon Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
315 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.